Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activations to food cues: Implications for plateauing weight loss in response to anti-obesity therapies

Obesity and Bariatric Surgery
Do you want to read an article? Please log in or register.